Best GLP-1 Provider With Patient Assistance in 2026 (and the Right Path for Your Insurance)

By the Weight Loss Provider Guide Editorial Team · Last verified: 2026-05-30 · Independent research

Verified May 30, 2026 · Insurance help, savings cards, prior-authorization support, and cash-pay fallback — all in one place.

Here's the honest answer up front. The best GLP-1 provider with patient assistance for most people with private insurance is Ro, because it checks your coverage before you pay anything, gives you a clear coverage report, and then has a team that fights your insurance paperwork for you. If you'd rather pick your own doctor or pay a lower yearly care fee, Sesame is the strongest backup. But here's the part almost every other page gets wrong: the famous “free medication” programs from the drugmakers do not cover the weight-loss drugs Wegovy or Zepbound. The free Novo Nordisk program covers Ozempic — a diabetes drug — for low-income, uninsured people, not Wegovy. So “patient assistance” for weight loss usually means something else entirely: a savings card, a cash-pay price, or a new government program. And which one fits you comes down to one thing: your insurance.

The phrase “patient assistance” is hiding at least six different things. Pick the wrong one and you'll waste money or get stuck in paperwork. Pick the right one and you could pay as little as $25 a month. Below, we map all six — with real 2026 prices — so you can find your path in about two minutes.

Find your path fast

What “GLP-1 patient assistance” actually means (it's six different things)

When you search “patient assistance,” you probably picture one thing: a program that gives you the medicine for free or close to it. That kind of program exists. It's called a Patient Assistance Program (PAP) — a charity-style program run by the drugmaker that gives free medicine to low-income people who don't have insurance.

Here's the catch nobody tells you.

The free PAPs are built around the diabetes drugs — not the weight-loss drugs.

• The Novo Nordisk PAP can give you free Ozempic (a diabetes drug) if you're uninsured and your household income is at or below 200% of the federal poverty level. But it does not cover Wegovy — the weight-loss version. Private insurance disqualifies you, too.
• Lilly Cares is a free-medication program for certain Eli Lilly drugs, for low-income patients who aren't on Medicaid, full Low-Income Subsidy, or VA benefits. But you have to check the current Lilly Cares medication list for your exact drug — and the weight-loss drug Zepbound is not on it. Don't count on Lilly Cares as a free Zepbound (or Mounjaro) path unless the live list confirms it.

So if you've been hunting for a “free Wegovy program,” that's why you keep hitting a wall. For weight loss, “patient assistance” almost always means one of the other five paths.

Six paths, six different people:

1. Insurance coverage check — “Does my plan even cover this?” (Start here if you have private insurance.)
2. Prior authorization (PA) help — PA is the extra paperwork your insurer makes your doctor file before they'll pay. Someone can do this for you.
3. Manufacturer savings card — a coupon that drops your cost to about $25/month, but only if you have private insurance.
4. Manufacturer PAP (free drug) — free medicine for low-income, uninsured people. Built around the diabetes drugs.
5. Government program — Medicare or Medicaid. Different rules entirely.
6. Cash-pay discount — pay out of pocket at the lowest honest price (often $149–$699/month now).

The wrong question is “Who has patient assistance?” Almost everyone claims they do. The right question is “Which path fits my insurance and my medication?” Answer that, and the rest is easy.

So what is the best GLP-1 provider with patient assistance?

We compared the real options the way you'd actually use them — not by who advertises hardest, but by who solves the specific problem: check my coverage, fight the paperwork, and give me a clear price if insurance fails.

Quick comparison: who helps with coverage, paperwork, and savings?

*Patient-Assistance Fit Score — our editorial score (out of 100) based on coverage checking, prior-auth help, savings clarity, cash-pay transparency, FDA-approved medication fit, government-plan honesty, and pricing transparency. It is not a medical-quality rating and not a promise your insurance will approve you. The scoring method is in “How we ranked these,” below.

Why Ro is the best first step for most people with private insurance

Most paid programs fold the coverage check into enrollment — you pay first, then find out what your insurance will do. Ro flips that. Its free coverage checker tells you, before you spend anything on medication, whether your plan may cover Ozempic, Wegovy, or Zepbound and roughly what you'd pay. New accounts also get a $50 credit. That's a real “look before you leap” tool, and it's the lowest-risk way to start.

If you do join, the insurance concierge (plain English: a team that does your paperwork) handles your prior authorization. If your insurer says no, they can resubmit or appeal. And if your plan prefers a different GLP-1, Ro's providers can switch you to one that's covered, when it's medically appropriate.

And if insurance just won't cover it? You're not stuck paying the scary list price. Ro sells the FDA-approved medicines at the same cash prices as the manufacturers — NovoCare, LillyDirect, and TrumpRx — starting at $149/month for the lower-dose Wegovy pill, with higher doses costing more. Ro carries Wegovy (pen and pill), Zepbound (vials and KwikPen), and the new Foundayo pill. It's also one of Novo Nordisk's official telehealth partners for the Wegovy self-pay subscription program.

One number worth knowing: about half of insured patients whose plan covers a weight-loss GLP-1 end up paying $50 a month or less, according to Ro's GLP-1 coverage checker report. That's the prize the paperwork unlocks.

What we verified for Ro: its free coverage checker, the insurance concierge, the $39 / $149 / $74 membership pricing, the manufacturer-matched cash prices, and its government-plan limitation. What we can't verify for you: your exact copay, your plan's formulary, or whether your prior authorization will be approved.

The one honest downside of Ro

Ro is not the cheapest care membership, and it is not built to bill Medicare, Medicaid, TRICARE, or VA coverage. If you're on a government plan, a paperwork team can't force those programs to approve you — so don't start here. (One exception Ro notes: federal employees on FEHB plans may be able to use the concierge.)

But here's why that “flaw” doesn't matter for the person Ro is built for: because Ro skips the government-billing maze, it can pour all its energy into the thing private-insurance shoppers need most — checking your coverage and winning the paperwork fight.

When Sesame is the better choice than Ro

Ro assigns you a clinician. Sesame lets you shop for one — you can read provider reviews and pick the person you want, then keep seeing them. For a lot of people, that control is worth a lot.

Sesame's price model is simple: you pay a flat care subscription, and medication is separate. The subscription is $99 every 28 days, or as low as $59/month if you commit to a year — which Sesame says saves you about $480 a year versus paying monthly. Medication cost depends on your insurance:

• With insurance + prior authorization: brand-name Wegovy or Zepbound can drop to as little as $25/month.
• Paying cash: Wegovy starts at $199/month for the lowest two doses (then $349), the Wegovy pill is about $149/month, and Zepbound starts at $299/month and runs up to roughly $699 at the highest doses — all matched to manufacturer pricing.
• Costco members: can get Wegovy or Ozempic injections for $349/month (about 50% off the usual cash price) through Sesame's Costco tie-in.

Sesame also has one of the broadest medication menus in this comparison, including FDA-approved weight-loss drugs and diabetes drugs that may be prescribed off-label when it's clinically appropriate. Lab work runs through Quest Diagnostics and is included in 41 states — the exceptions are AZ, HI, ND, NJ, NY, OK, RI, SD, and WY.

What we verified for Sesame: the $99 / $59 subscription pricing and $480 annual saving, the with-insurance and cash medication prices, the Costco pricing, and the lab-state exceptions. What we flagged: the conflict in Sesame's own materials about prior-authorization help.

Two more legit options: WW Med+ and PlushCare

The full 2026 GLP-1 assistance map (every path, every real price)

Last verified: May 30, 2026. We checked official manufacturer, provider, FDA, and CMS pages. We did not submit test insurance claims; your plan's decision is its own. Prices are public cash-pay or offer prices as of the verification date. Your final cost depends on eligibility, prescription, dose, insurance, pharmacy, refill timing, and program terms.

Notice the pattern: the lowest-cost rows that aren't telehealth — free PAPs where you qualify, low-copay Medicaid where it's covered, and the $50 Medicare Bridge — are government or charity routes, not telehealth-provider discounts. If you qualify for one of those, start there. They don't pay us a cent, and we'd rather you keep your money.

PAP income and insurance limits (the part people miss)

PAPs are strict, and most people get tripped up by the same two rules: you usually have to be uninsured, and your income has to be low.

• Novo Nordisk PAP (Ozempic): you must be uninsured, and your household income must be at or below 200% of the federal poverty level. Private insurance disqualifies you. Other Novo PAP products can use different income limits.
• Lilly Cares: for low-income patients who are not on Medicaid, full Low-Income Subsidy (“Extra Help”), or VA benefits — and only for drugs currently on the Lilly Cares list.

What will you actually pay after “patient assistance”?

Don't forget the care fee. Here's what a realistic monthly total looks like if you're paying cash:

• Ro + Wegovy pill: $74 membership (annual prepay) + $149 medication = ~$223/month.
• Ro + Zepbound vial (starter): $74 membership + $299 medication = ~$373/month.
• Sesame + Wegovy pen: $59 membership (annual) + $199 intro (then $349) medication = ~$258/month to start.
• PlushCare + insured Wegovy: $19.99 membership + a $129 visit (or copay) + your pharmacy copay — which can be as low as $25 if your plan covers it.

The jump from “$1,300” to “$25” usually comes down to one thing: does your plan cover anti-obesity medicine, and did the prior authorization go through? That's exactly the step a provider like Ro or Sesame helps with — and why checking your coverage first is the highest-value move you can make.

What if your PBM or employer changes your GLP-1 coverage?

Your drug can be covered one year and dropped the next — not because of your health, but because of a contract between your PBM and a drugmaker. Real example: CVS Caremark, the largest PBM in the U.S., dropped Zepbound from its standard plans on July 1, 2025 and made Wegovy the preferred option. In May 2026, after the backlash, CVS reversed course — Zepbound returns as a co-preferred option on October 1, 2026, and Foundayo gets added June 1, 2026.

Check your plan's drug list (its “formulary”) at open enrollment every year, and don't assume last year's coverage still holds. If your covered drug changes, a provider's insurance team can often switch you to the newly preferred GLP-1 or file an appeal — which is exactly what Ro's concierge and PlushCare's care team are for.

What if your GLP-1 prior authorization gets denied?

Don't panic at a “no.” Read why they said no. Some no's are fixable. Some aren't. Here's how to tell the difference fast.

• If it says “benefit exclusion” or “not a covered benefit” → your plan doesn't cover weight-loss drugs. Go cash-pay; paperwork won't help.
• If it says “missing clinical information” → resubmit with your BMI history and diagnoses.
• If it says “step therapy required” → document the lower-cost therapy your plan wants first.
• If it says “non-formulary” → ask your provider about the GLP-1 your plan does prefer.

The big one to understand is plan exclusion. That means your employer simply didn't buy weight-loss drug coverage. No amount of paperwork can force a benefit that isn't there. If that's your denial, stop paying anyone to file appeals — switch straight to a cash-pay or manufacturer-direct price.

What if you have Medicare, Medicaid, TRICARE, or VA coverage?

If you're on a government plan, you can't use the manufacturer savings cards that get private-insurance people to $25/month. That's federal law, not a company choice. And the telehealth “insurance concierge” services are built for private insurance, not Medicare or Medicaid. So a paperwork team usually can't help you the way it helps a privately insured person.

A note on diabetes and other conditions.

The Bridge is specifically for weight management. If your GLP-1 is prescribed for a condition Part D already covers — type 2 diabetes, obstructive sleep apnea, MASH (a liver condition), or heart-disease risk — you use your regular Part D plan for that drug, not the Bridge.

What if you have no insurance — or your plan blocks weight-loss drugs?

No insurance, or a plan that flat-out excludes weight-loss drugs? Skip the paperwork. It can't create coverage that doesn't exist. Your real options are cash-pay — and the good news is cash prices dropped hard in 2026.

• Manufacturer-direct: NovoCare (Wegovy) and LillyDirect (Zepbound, Foundayo) now sell straight to you. Wegovy runs $199 intro then $349/month; the Foundayo pill starts at $149/month; Zepbound runs $299–$449/month with LillyDirect's refill price, or up to $699 by dose otherwise.
• Price-matched providers: Ro and Sesame sell the same FDA-approved drugs at those same manufacturer prices, plus they handle the doctor visit and shipping.
• TrumpRx: A direct-purchase route listing the Wegovy pill from $149, the Wegovy pen and Ozempic from $199, and Zepbound from $299 at starting doses — brand-name only, no income rules.
• HSA/FSA: If you have a health savings or flexible spending account, you can often use it for visits, labs, and medication — real, immediate savings.

Are compounded GLP-1 providers a “patient assistance” program?

No. Compounded GLP-1s may be a cheaper cash-pay option (often $99–$299/month), but they are not FDA-approved finished drugs and are not manufacturer assistance. They are not savings-card eligible. The FDA has warned about unapproved and potentially counterfeit GLP-1 products, and in April 2026 proposed new restrictions on compounding these medications. Compounded telehealth can be an affordability fallback for a cash-pay person who can't use insurance and is comfortable with the changing rules — after a real medical review. It is not assistance, and it's not the same thing as an FDA-approved drug.

If that's your path, choose an established provider that works with licensed U.S. pharmacies, and see our separate compounded GLP-1 comparison.

Which provider is best for Wegovy, Zepbound, Ozempic, Mounjaro, or Foundayo?

• Wegovy (semaglutide, weight loss): Ro or Sesame for coverage help and matched cash prices; the Wegovy Savings Card if your plan covers it ($25/fill).
• Zepbound (tirzepatide, weight loss): Same — Ro or Sesame; the Zepbound Savings Card ($25/fill, pen track) if covered; LillyDirect for cash.
• Ozempic (semaglutide, diabetes): Coverage is usually easier if you have type 2 diabetes. If you're low-income and uninsured with diabetes, check the Novo Nordisk PAP — this is the rare free path.
• Mounjaro (tirzepatide, diabetes): Diabetes coverage is broader here too. If you're uninsured and low-income, check whether Mounjaro is on the current Lilly Cares list before counting on it.
• Foundayo (orforglipron, weight-loss pill): The newest option — an oral GLP-1 approved April 1, 2026, with self-pay from $149/month, $25/month with a commercial savings card, and Medicare Bridge access at $50/month. Ro carries it.

One tip: ask your provider whether your plan prefers one GLP-1 over another. Switching to the covered one (when it's right for you) is often the fastest way to a low copay.

Get ready: documents to gather before you check coverage

A coverage check is only as good as what you feed it. The most common reason a prior authorization stalls is missing paperwork — not a real “no.” Get these ready before you start:

How we ranked these GLP-1 providers

That's how Ro lands at 92, Sesame at 86, WW Med+ at 84, PlushCare at 80, and the manufacturer-direct route at 78.

What we actually verified (and what we didn't)

We believe in showing our work. On May 30, 2026, we checked:

• Ro's coverage checker, concierge, membership pricing, cash medication ranges, and government-plan limits.
• Sesame's subscription pricing, the $480 annual saving, medication prices, lab-state exceptions, and the prior-auth wording (including the contradiction in their own materials).
• WW Med+'s insurance coordinator, the $25-for-two-months-then-$74 pricing, and the 12-month auto-renewing plan.
• PlushCare's prior-auth workflow, $19.99/$149 pricing with a free first month, and its own ~$1,000/month out-of-pocket warning.
• NovoCare and LillyDirect savings and direct-pricing terms, and TrumpRx's listed prices.
• The Medicare GLP-1 Bridge dates, $50 copay, and mechanics directly from CMS.
• FDA statements on unapproved GLP-1s and the April 30, 2026 compounding proposal.
• CVS Caremark's May 2026 coverage changes for Zepbound and Foundayo.

What we did not verify, because it's personal to you:

• Your specific plan's formulary.
• Your exact copay or deductible.
• Whether your prior authorization will be approved.
• Whether a specific provider will prescribe a specific drug for you.
• Real-time pharmacy stock in your ZIP code.

The honest downsides of using a provider for patient assistance

• No one can guarantee approval. A provider improves your odds. It doesn't control your insurer.
• Membership is separate from medication. With Ro, Sesame, WW, and PlushCare, you pay for care and the drug. Budget for both.
• A plan exclusion is a hard stop. Paying someone to file appeals against a plan that excludes the drug is wasted money. Go cash-pay instead.
• Savings cards skip government plans. Medicare, Medicaid, VA, and TRICARE can't use them.
• Offers expire. Intro prices and savings caps change — that's why we date this page and re-check it monthly.
• Appeals take time. Prior authorization often takes one to two weeks. Plan for the wait.
• The medicine isn't for everyone. GLP-1s are prescription drugs with real risks and side effects, and a licensed clinician has to decide if they're right for you.

Frequently asked questions

Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth providers. We may earn a commission from affiliate links, which never changes our analysis, recommendations, or the prices you pay. Content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting any medication. Last verified: 2026-05-30.